U.S. Senate Passes Bill to Lower Prescription Drug Costs by Curtailing Barriers to Generic Medications

In a legislative move aimed at reducing the financial burden of prescription drugs, the U.S. Senate passed a bill on Thursday designed to halt pharmaceutical companies’ ability to divert patients from opting for generic drug versions. Proponents argue that this measure will significantly lower drug prices in the healthcare market. The initiative specifically targets tactics used by brand-name drug manufacturers to block competition from generics, which are often much cheaper for consumers and insurers. For more detailed coverage on this development, visit the original article on Law360.